DNA Topoisomerases as Anticancer Drug Targets
1990 · Advances in pharmacology · 195 citations
https://doi.org/10.1016/s1054-3589(08)60342-7
E
Erasmus Schneider
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
2.5K
Citations
24
h-index
39
i10-index
Erasmus Schneider is an academic researcher from New York State Department of Health. The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & Cancer therapeutics and mechanisms & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 24, co-authored 47 publications.
Papers by this author
worksBCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells
2000 · Biochemical Pharmacology · 112 citations
https://doi.org/10.1016/s0006-2952(00)00396-8
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and Iota
2022 · Communications Biology · 21 citations
https://doi.org/10.1038/s42003-022-03347-3
A structural analysis of in vitro catalytic activities of hammerhead ribozymes
2007 · BMC Bioinformatics · 13 citations
https://doi.org/10.1186/1471-2105-8-469
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat